XML 81 R69.htm IDEA: XBRL DOCUMENT v3.25.1
Note 13 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenues $ 42,886 $ 72,634  
Gross profit (loss) (5,080) (612)  
Net loss (24,529) (24,231)  
Interest expense including amortization of debt fees 13,693 10,513  
Accretion and other expenses of Series A preferred units 2,279 3,311  
Income tax (benefit) expense (6,783) 878  
Depreciation 2,357 1,798  
Stock-based compensation expense 2,308 2,969  
Other amortization 12 12  
EBITDA (10,663) (4,750)  
Capital expenditures 1,825 3,583  
Total assets 242,518 259,302 $ 259,302
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]      
Revenues 0 0  
Gross profit (loss) 0 0  
Net loss (9,669) (8,279)  
Interest expense including amortization of debt fees 3,828 2,699  
Accretion and other expenses of Series A preferred units 0 0  
Income tax (benefit) expense 11 0  
Depreciation 64 55  
Stock-based compensation expense 2,308 2,969  
Other amortization 0 0  
EBITDA (3,458) (2,556)  
Capital expenditures 146 329  
Total assets 35,306 38,526  
California Ethanol [Member] | Operating Segments [Member]      
Revenues 37,748 36,089  
Gross profit (loss) (4,938) (5,658)  
Net loss (14,910) (14,100)  
Interest expense including amortization of debt fees 8,461 6,753  
Accretion and other expenses of Series A preferred units 0 0  
Income tax (benefit) expense 0 0  
Depreciation 1,101 966  
Stock-based compensation expense 0 0  
Other amortization 12 12  
EBITDA (5,336) (6,369)  
Capital expenditures 43 107  
Total assets 52,165 57,076  
California Dairy Renewable Natural Gas [Member] | Operating Segments [Member]      
Revenues 2,443 3,792  
Gross profit (loss) 305 2,210  
Net loss 1,762 (3,166)  
Interest expense including amortization of debt fees 948 636  
Accretion and other expenses of Series A preferred units 2,279 3,311  
Income tax (benefit) expense (6,995) 35  
Depreciation 1,009 569  
Stock-based compensation expense 0 0  
Other amortization 0 0  
EBITDA (997) 1,385  
Capital expenditures 1,257 2,843  
Total assets 121,121 126,113  
India Biodiesel [Member] | Operating Segments [Member]      
Revenues 2,695 32,753  
Gross profit (loss) (447) 2,836  
Net loss (1,712) 1,314  
Interest expense including amortization of debt fees 456 425  
Accretion and other expenses of Series A preferred units 0 0  
Income tax (benefit) expense 201 843  
Depreciation 183 208  
Stock-based compensation expense 0 0  
Other amortization 0 0  
EBITDA (872) 2,790  
Capital expenditures 379 304  
Total assets $ 33,926 $ 37,587